172 related articles for article (PubMed ID: 35191993)
1. [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?].
Horn LC; Beckmann MW; Follmann M; Koch MC; Nothacker M; Pöschel B; Stübs F; Schmidt D; Höhn AK;
Pathologie (Heidelb); 2022 Jul; 43(4):292-302. PubMed ID: 35191993
[TBL] [Abstract][Full Text] [Related]
2. Updated Review on Pathology of Endocervical Adenocarcinoma with Emphasis on Clinically Relevant Findings.
Cimic A; Liu-Jarin X
Acta Med Acad; 2021 Apr; 50(1):126-135. PubMed ID: 34075768
[TBL] [Abstract][Full Text] [Related]
3. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
[TBL] [Abstract][Full Text] [Related]
4. Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.
Duggan MA; Duan Q; Pfeiffer RM; Brett MA; Lee S; Abubakar M; Köbel M; Rodriguez M; Sar A
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):91-98. PubMed ID: 34799503
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
6. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
[TBL] [Abstract][Full Text] [Related]
7. [The 2019 FIGO classification for cervical carcinoma-what's new?].
Horn LC; Brambs CE; Opitz S; Ulrich UA; Höhn AK
Pathologe; 2019 Nov; 40(6):629-635. PubMed ID: 31612260
[TBL] [Abstract][Full Text] [Related]
8. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
9. Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification.
Stolnicu S; Brito MJ; Karpathiou G; Hoang L; Felix A; Mateoiu C; Fanni D; Reques A; Garcia A; Hardisson D; Talu CK; Furtado A; Abu-Rustum N; Soslow RA; Park KJ
Int J Gynecol Pathol; 2023 May; 42(3):270-277. PubMed ID: 36508680
[TBL] [Abstract][Full Text] [Related]
10. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
[TBL] [Abstract][Full Text] [Related]
11. The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists.
Alvarado-Cabrero I; Parra-Herran C; Stolnicu S; Roma A; Oliva E; Malpica A
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S48-S65. PubMed ID: 33570863
[TBL] [Abstract][Full Text] [Related]
12. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
[TBL] [Abstract][Full Text] [Related]
13. International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.
Hodgson A; Park KJ; Djordjevic B; Howitt BE; Nucci MR; Oliva E; Stolnicu S; Xu B; Soslow RA; Parra-Herran C
Am J Surg Pathol; 2019 Jan; 43(1):75-83. PubMed ID: 29877920
[TBL] [Abstract][Full Text] [Related]
14. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
15. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
[TBL] [Abstract][Full Text] [Related]
17. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
[No Abstract] [Full Text] [Related]
18. Grading of endocervical adenocarcinoma: a novel prognostic system based on tumor budding and cell cluster size.
Shi H; Ye L; Lu W; Lu B
Mod Pathol; 2022 Apr; 35(4):524-532. PubMed ID: 34593968
[TBL] [Abstract][Full Text] [Related]
19. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
20. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
Park KJ; Roma A; Singh N; Gilks CB; Oliva E; Abu-Rustum N; Ramirez PT; McCluggage WG
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S92-S101. PubMed ID: 33570866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
